FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.810
+0.050 (2.84%)
At close: Sep 4, 2026, 4:00 PM EDT
1.850
+0.040 (2.21%)
After-hours: Sep 4, 2026, 5:39 PM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $12.05 million as of September 4, 2026. Its market cap has decreased by -52.29% in one year.
Market Cap
12.05M
Enterprise Value
10.00M
1-Year Change
-52.29%
Ranking
Category
Stock Price
$1.81
ChartMarket Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $12.05M, a decrease of -98.73%. That is a compound annual growth rate of -81.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 12.05M | -19.44% |
| Dec 31, 2025 | 14.96M | -78.68% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioLineRx | 12.20M |
| MetaVia | 12.19M |
| Theriva Biologics | 11.43M |
| GT Biopharma | 11.42M |
| Xenetic Biosciences | 11.34M |
| Kiora Pharmaceuticals | 11.33M |
| IN8bio | 11.24M |
| Daré Bioscience | 11.01M |